These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 39210487)
1. [Changes in the disease burden of male urinary and reproductive system tumors in China from 1990 to 2019: Analysis with a prediction of the future trend]. Shou MY; Zheng N; Liu YX; Wu XY; Fang RR; Sun N Zhonghua Nan Ke Xue; 2024 May; 30(5):397-403. PubMed ID: 39210487 [TBL] [Abstract][Full Text] [Related]
2. Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021. Zi H; Liu MY; Luo LS; Huang Q; Luo PC; Luan HH; Huang J; Wang DQ; Wang YB; Zhang YY; Yu RP; Li YT; Zheng H; Liu TZ; Fan Y; Zeng XT Mil Med Res; 2024 Sep; 11(1):64. PubMed ID: 39294748 [TBL] [Abstract][Full Text] [Related]
3. Global Burden of Urologic Cancers, 1990-2013. Dy GW; Gore JL; Forouzanfar MH; Naghavi M; Fitzmaurice C Eur Urol; 2017 Mar; 71(3):437-446. PubMed ID: 28029399 [TBL] [Abstract][Full Text] [Related]
4. Disparities and Trends in Genitourinary Cancer Incidence and Mortality in the USA. Schafer EJ; Jemal A; Wiese D; Sung H; Kratzer TB; Islami F; Dahut WL; Knudsen KE Eur Urol; 2023 Jul; 84(1):117-126. PubMed ID: 36566154 [TBL] [Abstract][Full Text] [Related]
5. Association of Human Development Index with global bladder, kidney, prostate and testis cancer incidence and mortality. Greiman AK; Rosoff JS; Prasad SM BJU Int; 2017 Dec; 120(6):799-807. PubMed ID: 28480994 [TBL] [Abstract][Full Text] [Related]
6. Trends and risk factors of global incidence, mortality, and disability of genitourinary cancers from 1990 to 2019: Systematic analysis for the Global Burden of Disease Study 2019. Tian YQ; Yang JC; Hu JJ; Ding R; Ye DW; Shang JW Front Public Health; 2023; 11():1119374. PubMed ID: 36908450 [TBL] [Abstract][Full Text] [Related]
7. Secular trends of morbidity and mortality of prostate, bladder, and kidney cancers in China, 1990 to 2019 and their predictions to 2030. Huang Q; Zi H; Luo L; Li X; Zhu C; Zeng X BMC Cancer; 2022 Nov; 22(1):1164. PubMed ID: 36368976 [TBL] [Abstract][Full Text] [Related]
8. Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990-2019. Zi H; He SH; Leng XY; Xu XF; Huang Q; Weng H; Zhu C; Li LY; Gu JM; Li XH; Ming DJ; Li XD; Yuan S; Wang XH; He DL; Zeng XT Mil Med Res; 2021 Nov; 8(1):60. PubMed ID: 34819142 [TBL] [Abstract][Full Text] [Related]
9. Bladder, penile, renal pelvis and testis cancers: A population based analysis of incidence and survival 1977-2013. Tempo J; Logan C; O'Callaghan M; Kahokehr A; Kichenadasse G; D'Onise K; Foreman D Cancer Epidemiol; 2020 Apr; 65():101692. PubMed ID: 32151978 [TBL] [Abstract][Full Text] [Related]
10. Mortality Trends from Urologic Cancers in Europe over the Period 1980-2017 and a Projection to 2025. Bertuccio P; Santucci C; Carioli G; Malvezzi M; La Vecchia C; Negri E Eur Urol Oncol; 2021 Oct; 4(5):677-696. PubMed ID: 34103280 [TBL] [Abstract][Full Text] [Related]
11. [Comparison of Disease Burden Factors of Thyroid Cancer Between China and the World From 1990 to 2019]. Su W; Xu YT; Wang YN; Wu YY; Wan W; Gao WQ; Gao Y; Shi YY; Ma S Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Dec; 45(6):940-948. PubMed ID: 38173105 [TBL] [Abstract][Full Text] [Related]
12. [Disease burden of prostate cancer among men in China, from 1990 to 2013]. Qi JL; Wang LJ; Zhou MG; Liu YN; Liu JM; Liu SW; Zeng XY; Yin P Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jun; 37(6):778-82. PubMed ID: 27346101 [TBL] [Abstract][Full Text] [Related]
13. Urologic cancer in China. Pang C; Guan Y; Li H; Chen W; Zhu G Jpn J Clin Oncol; 2016 Jun; 46(6):497-501. PubMed ID: 27049022 [TBL] [Abstract][Full Text] [Related]
14. Incidence of kidney, bladder, and prostate cancers in Korea: An update. Song W; Jeon HG Korean J Urol; 2015 Jun; 56(6):422-8. PubMed ID: 26078838 [TBL] [Abstract][Full Text] [Related]
15. Changes in disease burden and global inequalities in bladder, kidney and prostate cancers from 1990 to 2019: a comparative analysis based on the global burden of disease study 2019. Huang Q; Yang J; Liu GX; Zi H; Tang SD; Jia HC; Li W; Xu XF; Zeng XT BMC Public Health; 2024 Mar; 24(1):891. PubMed ID: 38528465 [TBL] [Abstract][Full Text] [Related]
16. Difference in the incidences of the most prevalent urologic cancers from 2003 to 2009 in Iran. Basiri A; Shakhssalim N; Jalaly NY; Miri HH; Partovipour E; Panahi MH Asian Pac J Cancer Prev; 2014; 15(3):1459-63. PubMed ID: 24606483 [TBL] [Abstract][Full Text] [Related]
17. [Common Malignant Tumors in the Reproductive System of Chinese Women: Disease Burden During 1990-2019 and Prediction of Future Trend]. Zheng N; Tang J; Ren XM Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Feb; 46(1):25-32. PubMed ID: 38433627 [TBL] [Abstract][Full Text] [Related]
18. Increasing occurrence of urological cancers in Slovakia. Plesko I; Obsitnikova A; Cuninkova M; Tomasek L; Stefanakova D; Kubik A Neoplasma; 2004; 51(4):248-54. PubMed ID: 15254654 [TBL] [Abstract][Full Text] [Related]
19. [Disease burden of colorectal cancer in China: any changes in recent years?]. Wang H; Cao MD; Liu CC; Yan XX; Huang HY; Zhang Y; Chen HD; Ren JS; Li N; Chen WQ; Dai M; Shi JF Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1633-1642. PubMed ID: 33297619 [No Abstract] [Full Text] [Related]
20. Analysis and prediction of central nervous system tumor burden in China during 1990-2030. Qi Z; Yu H; Chen L; Qu Y; Zhang M; Qi G; Chen S PLoS One; 2024; 19(4):e0300390. PubMed ID: 38630737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]